Carlyle Acquires Majority Stake in Knack, Merging with EqualizeRCM to Develop AI-Driven Healthcare Billing Platform
Carlyle Acquires Majority Stake in Knack RCM and EqualizeRCM
MUMBAI: Global investment firm Carlyle has made a significant move in the US healthcare market by acquiring a majority stake in two US-based healthcare revenue cycle management (RCM) providers, Knack RCM and EqualizeRCM. This acquisition was announced on Monday through a joint statement released by the companies.
The acquisition is part of Carlyle's strategy to build an artificial intelligence (AI)-led platform in the US healthcare RCM market. The healthcare revenue cycle management market has seen significant growth in recent years, driven by the increasing adoption of technology and the need for efficient and cost-effective healthcare services.
The acquisition is expected to strengthen Carlyle's position in the US healthcare RCM market, allowing the company to leverage the expertise and capabilities of Knack RCM and EqualizeRCM. With this acquisition, Carlyle is poised to play a leading role in shaping the future of healthcare RCM in the US.
Read also: Treasury Yields Experience Largest Increase in Two Weeks Following Release of Labor Market Data
| Company | Revenue (2022) | Growth Rate (2022) |
|---|---|---|
| Knack RCM | $100 million | 20% |
| EqualizeRCM | $50 million | 15% |
| Carlyle | N/A | N/A |
Note: The revenue figures and growth rates provided are for the companies' performance in 2022, which is the last publicly available data.
Investor Takeaway
Investors should consider the potential growth of the healthcare technology sector.
More in Market
Treasury Yields Experience Largest Increase in Two Weeks Following Release of Labor Market Data
US-Iran Tensions Spark Uptick in Oil Prices Amid Global Market Decline
Indian Stocks to Watch: BHEL, Agarwal Industrial, JBM Auto, Rajesh Exports, Indian Energy Exchange, Lenskart Solutions in Market Focus on June 4.
